Alice Shaw, MD, Ph.D, GRACE Faculty

Alice Shaw, MD, Ph.D, Director of the Center for Thoracic Cancers
Massachusetts General Hospital
Boston
MA
Specialties
Thoracic Cancers

Alice T. Shaw is the Director of the Center for Thoracic Cancers and the Paula O’Keeffe Endowed Chair of Thoracic Oncology at Massachusetts General Hospital. She is also an Associate Professor of Medicine at Harvard Medical School. She received her A.B. in Biochemistry from Harvard and her M.D. and Ph.D. degrees from Harvard Medical School. She did her residency in Internal Medicine at Massachusetts General Hospital and completed a fellowship in Hematology/Oncology at Dana-Farber/Massachusetts General Hospital. She completed her postdoctoral work in the laboratory of Dr. Tyler Jacks at MIT.

In addition to caring for patients with lung cancer, Dr. Shaw also performs clinical and translational research. Her clinical research focuses on a variety of different molecularly defined subsets of non-small cell lung cancer (NSCLC). Her translational research focuses on elucidating mechanisms of resistance to targeted therapies. Based on her research, she has helped to develop numerous FDA-approved targeted therapies for patients with oncogene-driven NSCLC, and her current efforts focus on developing novel combinatorial strategies aimed at overcoming drug resistance.

Dr. Shaw has been awarded a number of research grants, including grants from the Damon Runyon Cancer Research Foundation, the Burroughs Wellcome Fund, the V Foundation for Cancer Research, Uniting Against Lung Cancer, the National Foundation for Cancer Research, SU2C/AACR/ACS, and the NIH/NCI. In 2014 she was elected as a member to the American Society of Clinical Investigation. She is a standing member of the FDA Oncologic Drugs Advisory Committee and she recently joined the LUNGevity Foundation Scientific Advisory Board.

Conflict of Interest

None

Dr. Alice Shaw joined GRACE to discuss the changing landscape of first-line treatment of ALK-positive advanced non-small cell lung cancer.

Dr. Alice Shaw joined GRACE to discuss patterns of resistance in ALK positive non small cell lung cancer.

Dr. Alice Shaw joined GRACE to discuss controlling brain metastases in patients with molecular driven advanced non-small cell lung cancer.

Forum Discussions

Original post date: 2022-02-21

Hi all -- share your cancer journey here and connect with others.  Cancer.gov has a good general description of Cholangiocarcinoma.  This rare disease has support information and programs that can be

Last Activity: Mon, 02/21/2022 - 11:15
Original post date: 2022-02-04

Keep your eye out for new Head and Neck information soon! 

Last Activity: Sat, 02/05/2022 - 12:12
Original post date: 2022-02-01

Gallbladder Cancer is a rare disease in which malignant cells form in the tissues of the gallbladder.  Bile duct cancer or cholangiocarcinoma is a rare disease in which malignant cells form in the

Last Activity: Tue, 02/01/2022 - 16:16
Original post date: 2021-11-24

The happiest of Thanksgiving to everyone! Thank you for being a part of GRACE!

Image
Happy Thanksgiving!
Last Activity: Thu, 12/02/2021 - 15:33
Original post date: 2021-01-07
The research team at Tulane University is conducting an online survey of individuals with cancer. 

GRACE has been asked to share information about an anonymous one-time online research study about

Last Activity: Thu, 01/07/2021 - 15:55

Comments

Post Date: 2022-04-12

You may find our clinical trial page helpful, also.  https://cancergrace.org/find-clinical-trials.  

Post Date: 2022-02-04

Keep your eye out for new Head and Neck information soon! 


This comment has been promoted to its

Post Date: 2021-12-02

Janine I am so happy to hear things like this. What you can or feel comfortable sharing, know that

Post Date: 2021-07-19

Hi all!  

The 2021 Targeted Therapies Patient Forum is now available ON Demand!  

Click below to